Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D3KO5Y
|
|||
| Drug Name |
Elranatamab
|
|||
| Synonyms |
PF-06863135
Click to Show/Hide
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Multiple myeloma [ICD-11: 2A83; ICD-10: C90] | Approved | [1] | |
| Company |
Pfzer
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | B-cell maturation protein (TNFRSF17) | Target Info | . | [1] |
| T-cell surface glycoprotein CD3 (CD3) | Target Info | . | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2023. Application Number: 761345 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.